British Virgin Islands vs Saint Barthélemy: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
British Virgin Islands
0.2%
in 2024
Saint Barthélemy
0.2%
in 2024
British Virgin Islands rank
98th
Saint Barthélemy rank
98th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- British Virgin Islands
- Saint Barthélemy
How they compare
British Virgin Islands currently reports 0.2% against 0.2% in Saint Barthélemy, a difference of 0.0%.
Across all 10 years both countries report, Saint Barthélemy has been ahead every year.
British Virgin Islands ranks 98th and Saint Barthélemy ranks 98th of 246 countries.
Head to head by decade
| Decade | British Virgin Islands | Saint Barthélemy | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.3% | 0.0% | — |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, British Virgin Islands or Saint Barthélemy?
- British Virgin Islands, at 0.2% against 0.2% in Saint Barthélemy as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between British Virgin Islands and Saint Barthélemy?
- 0.0%, with British Virgin Islands ahead.
- How many years of comparable data are there for British Virgin Islands and Saint Barthélemy?
- 10 years are reported by both, from 2015 to 2024.
- How do British Virgin Islands and Saint Barthélemy rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- British Virgin Islands ranks 98th and Saint Barthélemy ranks 98th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.